Correction
This article was originally published in The Gray Sheet
Executive Summary
A story in the Aug. 27 issue erroneously referred to a patent reform bill (H.R. 1908) as "House-approved" (1"The Gray Sheet" Aug. 27, 2007, p. 3). The bill cleared the House Judiciary Committee, but has not yet been put to a vote on the House floor...
You may also be interested in...
Patent Rule Limits Applications, Impacting Device Makers’ Filing Strategies
A highly anticipated final 1rule from the U.S. Patent and Trademark Office puts new limits on the number of applications a company can file for any single invention, potentially requiring changes in device manufacturers' patent strategies
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.